Results 171 to 180 of about 409,890 (320)

A Data‐Driven Epigenetic Characterization of Morning Fatigue Severity in Oncology Patients Receiving Chemotherapy: Associations With Epigenetic Age Acceleration, Blood Cell Types, and Expression‐Associated Methylation

Cancer Medicine, Volume 14, Issue 15, August 2025.
Fatigue is commonly associated with cancer and its treatments and has a negative impact on patients' ability to tolerate treatments and on their quality of life. This epigenetic characterization of morning fatigue in patients receiving chemotherapy finds biological aging, gene regulatory, and inflammatory processes associated with morning fatigue ...
Caroline Le, Maureen Lewis, Carolyn S. Harris, Liam Berger, Esther Chavez‐Iglesias, Lisa Morse, Anatol Sucher, Ritu Roy, Adam Olshen, Marilyn J. Hammer, Steve Paul, Margaret Wallhagen, Raymond Chan, Michael Sayer, Sue Yom, Nam‐Woo Cho, Alexandre Chan, Jon Levine, Anand Dhruva, Christine Miaskowski, Yvette P. Conley, Kord M. Kober   +21 more
wiley   +1 more source

Induction of mammary neoplasms in the SPrague-Dawley rat by 430 keV neutrons and X-rays [PDF]

, 1980
Chmelevsky, D., Kellerer, Albrecht M., Shellabarger, C. J.   +2 more
core   +1 more source

Brain metastases from a thymoma: Case report for a rare secondary localization

Radiology Case Reports
Thymomas are benign epithelial neoplasms originating from the thymus gland and are among the most common primary mediastinal tumors. Malignancy is typically determined by evidence of pathological invasion beyond the capsule, with local invasion being the
Ghassen Gader, Skander Guediche, Ines Moussa, Sinda Ben Zekri, Mohamed Badri, Ahmed Harbaoui, Ihsèn Zammel   +6 more
doaj  

Treatment of thymoma with low-dose glucocorticoids before surgery for significant tumor shrinkage: A case report. [PDF]

World J Clin Cases
Yao JK, He ZY, Zhu Z, Huang HT.
europepmc   +1 more source

Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms

Endocrine pathology, 2018
S. Uccella, S. La Rosa, M. Volante, M. Papotti   +3 more
semanticscholar   +1 more source

Dose Selection for DuoBody®‐CD40x4‐1BB (GEN1042/BNT312) Using a mPBPK/RO Model Leveraging Preclinical and Clinical Data

Clinical Pharmacology &Therapeutics, Volume 118, Issue 2, Page 418-427, August 2025.
Optimizing target engagement for bispecific antibodies (bsAbs) is challenging, as bsAbs bind to two different targets in vivo to form a trimolecular complex (trimer), and likely display a bell‐shaped concentration–response curve. bsAbs trimer formation is expected to be related to efficacy and safety, and determining the dose level at which it is ...
Gaurav Bajaj, Dmitry Shchelokov, Oleg Demin Jr, Homer C. Adams 3rd, Yan Feng, Leonid Gibiansky, Saskia van der Lee, Anandhi Johri, Merzu Belete, Alexander Muik, Porntula Panorchan, Özlem Türeci, Uğur Sahin, Tahamtan Ahmadi, Manish Gupta, Oleg Demin, Craig Thalhauser   +16 more
wiley   +1 more source

Hepatocellular carcinoma escapes immune surveillance through deceiving thymus into recalling peripheral activated CD8⁺ T cells. [PDF]

Neoplasia
Hu Q, Wang X, You Y, Liu J, Lan B, Chen F, Wen H, Cheng H, Zhuo W, Xu T, Zheng J, Jiang Y, Wang X, Lin J, Guo Z, Huang S, Chen G, Chen Y, Liu J.   +18 more
europepmc   +1 more source

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events

ESC Heart Failure, Volume 12, Issue 4, Page 2404-2416, August 2025.
Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna, Elia Rigamonti, Raffaele Zannoni, Vittoria Espeli, Giorgio Moschovitis   +4 more
wiley   +1 more source

Recent Clinical and Molecular Advances in the Management of Thymic Carcinoids: A Comprehensive Review. [PDF]

Cancers (Basel)
Piórek A, Płużański A, Kowalski DM, Krzakowski M.   +3 more
europepmc   +1 more source

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Chemotherapy

Neuroendocrinology, 2017
R. García-Carbonero, A. Rinke, J. Valle, N. Fazio, M. Caplin, V. Gorbounova, J. O'Connor, B. Eriksson, H. Sorbye, M. Kulke, Jie Chen, Jenny Falkerby, F. Costa, W. D. de Herder, C. Lombard-Bohas, M. Pavel   +15 more
semanticscholar   +1 more source